JPH0374321A - Bathing agent - Google Patents
Bathing agentInfo
- Publication number
- JPH0374321A JPH0374321A JP1206986A JP20698689A JPH0374321A JP H0374321 A JPH0374321 A JP H0374321A JP 1206986 A JP1206986 A JP 1206986A JP 20698689 A JP20698689 A JP 20698689A JP H0374321 A JPH0374321 A JP H0374321A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- carbonate
- layer
- foaming bath
- bath additive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003287 bathing Methods 0.000 title abstract description 4
- 239000002253 acid Substances 0.000 claims abstract description 30
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 28
- 239000000049 pigment Substances 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 4
- 230000007812 deficiency Effects 0.000 claims abstract 3
- 239000003205 fragrance Substances 0.000 claims description 24
- 239000000654 additive Substances 0.000 claims description 18
- 238000005187 foaming Methods 0.000 claims description 15
- 239000000314 lubricant Substances 0.000 claims description 15
- 230000000996 additive effect Effects 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000013040 bath agent Substances 0.000 claims 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 10
- 230000006866 deterioration Effects 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 239000001569 carbon dioxide Substances 0.000 abstract description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 5
- 239000002304 perfume Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 238000013329 compounding Methods 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 55
- 239000003826 tablet Substances 0.000 description 31
- 239000004615 ingredient Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 9
- 241000411851 herbal medicine Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- -1 sucrose fatty acid ester Chemical class 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000016704 Achillea millefolium ssp. borealis Nutrition 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229940080423 cochineal Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000007942 layered tablet Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は浴湯に投入すると酸と炭酸塩との反応により炭
酸ガスを発生する発泡入浴剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a foaming bath additive that generates carbon dioxide gas through a reaction between acid and carbonate when added to bath water.
炭酸ガスを発生しながら溶解する入浴剤は従来より酸と
炭酸塩を混合し打錠しているものが多くこの場合打錠時
の圧力と環境からの水分及び原料中の水分により打錠障
害（ステイキング）が発生し成形不能になる。このステ
イキングを防止する為種々の滑沢剤を配合し打錠を行っ
ているが滑沢剤を多く使用すると滑沢剤が浴湯面に浮い
たり、浴湯を濁らせたりする等の問題点を生じ未だ充分
ではない。Traditionally, many bath additives that dissolve while generating carbon dioxide gas are made into tablets by mixing acids and carbonates, and in this case, tableting failure occurs due to pressure during tableting, moisture from the environment, and moisture in raw materials. Staking) occurs, making molding impossible. In order to prevent this staking, various lubricants are blended into tablets, but if too much lubricant is used, there are problems such as the lubricants floating on the surface of the bath water or making the bath water cloudy. This is still not sufficient.
また、香料や色素は原料に同時に混合され打錠を行って
いるため、香料や色素が錠剤全体に均一に配合されてお
り、溶解時の香りゃ色の変化がなくおもしろみのない単
言周なものであった。In addition, since flavorings and dyes are mixed with the raw materials at the same time and compressed into tablets, the flavorings and dyes are evenly blended throughout the tablet, resulting in no change in scent or color during dissolution, which makes it uninteresting. It was something.
さらに従来技術においては、オイルや生薬抽出物、酵素
、ビタミン等の添加物を配合し打錠すると上記に示した
ステイキングがさらに助長されるとともに、これら成分
の劣化を生しるという問題点を有していた。Furthermore, in the conventional technology, when additives such as oils, herbal medicine extracts, enzymes, vitamins, etc. are blended into tablets, the above-mentioned staking is further promoted and these ingredients deteriorate. had.
本発明の課題は、従来技術の有する上記問題点を解消す
ることにあり、まず多量の滑沢剤を使用せずに打錠時に
おいてステイキングを有効に防止し得る発泡入浴剤を提
供することにあり、また、浴場溶解時において色や香り
の変化を楽しめる発泡入浴剤を提供することにあり、さ
らに、打錠時においてステイキングを生しることなく、
オイル、生薬抽出物、酵素、ビタくン等を配合し得ると
ともにこれら成分の劣化を生しることのない発泡入浴剤
を提供することにある。The object of the present invention is to solve the above-mentioned problems of the prior art, and first, to provide a foaming bath additive that can effectively prevent staking during tableting without using a large amount of lubricant. Another purpose is to provide a foaming bath additive that allows you to enjoy changes in color and scent when dissolved in the bath, and furthermore, does not cause staking during tableting.
To provide a foaming bath additive which can contain oil, crude drug extracts, enzymes, vitamins, etc. and does not cause deterioration of these components.
本発明者等は、炭酸ガス発泡錠における打錠障害（ステ
イキング）の原因を解明すべく鋭意研究を行った結果、
打錠時の圧力と、環境からの水分及び原料からの水分に
より、杵と原料が接触する部分で発泡成分である酸と炭
酸塩の反応が促進されてしまい、この局所的反応により
微量な水分と炭酸ガスを生威し、この微量水分によりス
テイキングが起こることを確認した。さらに詳細な検討
により、オイルや生薬抽出物、酵素等の添加物を配合し
打錠すると原因は不明であるがステイキングが起こりや
すくまた錠剤表面でこれらの添加物の変質や失活を生し
ることも確認した。The inventors of the present invention have conducted intensive research to elucidate the cause of tableting failure (staking) in carbon dioxide effervescent tablets.
Pressure during tablet compression, moisture from the environment, and moisture from the raw materials accelerate the reaction between the acid and carbonate, which are foaming ingredients, in the area where the punch and raw materials come into contact, and this local reaction causes trace amounts of moisture to be released. and carbon dioxide gas, and confirmed that staking occurs due to this trace amount of moisture. Further detailed studies revealed that, although the cause is unknown, staking tends to occur when additives such as oils, herbal medicine extracts, enzymes, etc. It was also confirmed.
そして、本発明者等はこのような打錠障害（ステイキン
グ）の原因を考察して、杵に接触する部分すなわち錠剤
の上下層においては酸と炭酸塩の反応が生じにくい組成
にし、ステイキングを防止するための滑沢剤をこれらの
上下層に配合し二層とするか、更にこの二層の間にステ
イキングを生じやすい成分あるいは失活、変質しやすい
成分を中間層の形で組み入れ三層構造をもった錠剤にす
れば多量の滑沢剤を使用せずに打錠時におけるステイキ
ングを防止するだけでなく配合成分の劣化変質を有効に
防止し得ることを見い出し本発明を完成するに至ったも
のである。The present inventors considered the causes of such tableting problems (staking) and created a composition in which the reaction between acid and carbonate is less likely to occur in the portions that come into contact with the punch, that is, the upper and lower layers of the tablet, thereby reducing staking. Either a lubricant is added to the upper and lower layers to prevent this, creating a two-layer structure, or an intermediate layer containing ingredients that tend to cause staking, deactivation, or deterioration are added between these two layers. The present invention was completed after discovering that by making tablets with a three-layer structure, it is possible to not only prevent staking during tablet compression without using a large amount of lubricant, but also effectively prevent deterioration of the ingredients. This is what I came to do.
以下、本発明をさらに詳細に説明する。The present invention will be explained in more detail below.
錠剤の上下層において酸と炭酸塩を一緒に配合せず、酸
と炭酸塩とを上下層と中間層とに分けて配合すれば、杵
と接触する部分での反応は起こらず、ステイキングは起
こりにくくなるが上下層と中間層との結合が弱（なり、
浴場溶解時に分離（剥離現象）が起こってしまう。その
為、本発明においては各層において酸と炭酸塩を完全に
分けて配合せず、上下層においては酸及び炭酸塩のいず
れか一方の配合量が、他方に対して化学当量に換算して
少なくなるように配合する。この場合、酸及び炭酸塩の
当量比は０．０５〜Ｏ，５：１又は１：０．０５〜０．
５が好ましく、この配合割合の範囲内においては反応が
抑制され打錠時のステイキングは生しない。If the acid and carbonate are not mixed together in the upper and lower layers of the tablet, but are mixed separately in the upper and lower layers and the middle layer, no reaction will occur at the part that comes into contact with the punch, and staking will be prevented. This will be less likely to occur, but the bond between the upper and lower layers and the middle layer will be weak.
Separation (peeling phenomenon) occurs during bath dissolution. Therefore, in the present invention, the acid and carbonate are not completely separated and blended in each layer, and in the upper and lower layers, the blended amount of either acid or carbonate is smaller than the other in terms of chemical equivalent. Mix it so that it becomes the same. In this case, the equivalent ratio of acid and carbonate is 0.05-0, 5:1 or 1:0.05-0.
5 is preferable, and within this blending ratio range, the reaction is suppressed and staking does not occur during tableting.
しかし、本発明の入浴剤は、酸と炭酸塩との反応により
発泡させることを利用するものであるから、適度の発泡
を生じさせるために、三層構造にした場合には上中下層
あわせて、二層構造にした場合には上下層あわせて、酸
と炭酸塩の当量比として０．７〜１．３：１になるよう
に配合することが好ましい。However, since the bath additive of the present invention utilizes foaming caused by the reaction between acid and carbonate, in order to generate appropriate foaming, when it has a three-layer structure, the upper, middle, and lower layers are combined. In the case of a two-layer structure, it is preferable that the equivalent ratio of acid and carbonate in the upper and lower layers is 0.7 to 1.3:1.
例えば三層構造では、上層と下層の組成は同一または異
なって前述の配合割合の範囲内の値をとることができ、
不足分の酸または炭酸塩は中間組成で補うことになる。For example, in a three-layer structure, the compositions of the upper layer and the lower layer can be the same or different and can take values within the range of the above-mentioned blending ratio,
The missing acid or carbonate will be compensated for by the intermediate composition.
そしてこれらのことにより、打錠時のステイキングを防
止するとともに錠剤の浴場溶解時の剥離現象を防止し、
かつ良好な発泡性を維持できる。These things prevent staking during tablet compression, and prevent peeling when tablets are dissolved in a bath.
And good foamability can be maintained.
本発明において使用する酸及び炭酸塩としては、例えば
以下のものが挙げられる。Examples of acids and carbonates used in the present invention include the following.
〈酸〉
クエン酸、コハク酸、リンゴ酸、フマル酸、酒石酸、ア
ジピン酸、グルタミン酸、ピロリドンカルボン酸
〈炭酸塩〉
重曹、炭酸ソーダ、炭酸カリウム１炭酸水素カリウム、
セスキ炭酸ソーダ
滑沢剤は、ステイキングを防止するために用いられるが
、効果を得る為には多く配合することが必要である為、
溶解時この滑沢剤が浴場面に浮いたり浴湯を濁らせたり
する。そこで本発明においては打面に接触する上層と下
層のみに屑沢剤を配合し、中間層には配合しないで打面
と接触する部分の滑沢剤濃度を上げ全体的に滑沢剤濃度
を抑えることにより本問題点を解決することが出来た。<Acid> Citric acid, succinic acid, malic acid, fumaric acid, tartaric acid, adipic acid, glutamic acid, pyrrolidone carboxylic acid <Carbonate> Baking soda, soda carbonate, potassium carbonate 1 potassium bicarbonate,
Sodium sesquicarbonate lubricant is used to prevent staking, but it is necessary to add a large amount to obtain the effect.
When dissolved, this lubricant floats on the bath surface and makes the bath water cloudy. Therefore, in the present invention, a lubricant is added only to the upper and lower layers that contact the hitting surface, and is not added to the middle layer, increasing the lubricant concentration in the parts that come into contact with the hitting surface, thereby increasing the overall lubricant concentration. By suppressing this, we were able to solve this problem.
上下層の滑沢剤配合率は０．５〜７０％であり、全体的
に０．０１〜７％の使用が好ましい。The blending ratio of the lubricant in the upper and lower layers is 0.5 to 70%, preferably 0.01 to 7% overall.
本発明においては、滑沢剤として例えば、ステアリン酸
マグネシウム、ステアリン酸、ステアリン酸す１−リウ
ム、シヨ糖脂肪酸エステル、タルクシリカ、軽質無水ケ
イ酸、デンプン、微結晶セルロース、ステアリン酸アル
コール、ステアリン酸カルシウム、ポリエチレングリコ
ール６０００． ポリエチレングリコール５ｏｏｏ、ポ
リエチレングリコール］ ００００． ポリエチレング
リコール２００００．ヒドロキシプロピルセルロースあ
るいはメトキシヒドロキシプロポキシセルロース等を用
いることができる。In the present invention, the lubricant includes, for example, magnesium stearate, stearic acid, mono-lium stearate, sucrose fatty acid ester, talc silica, light silicic anhydride, starch, microcrystalline cellulose, stearic alcohol, calcium stearate, Polyethylene glycol 6000. Polyethylene glycol 5ooo, polyethylene glycol] 0000. Polyethylene glycol 20000. Hydroxypropylcellulose, methoxyhydroxypropoxycellulose, etc. can be used.
また、オイル、生薬抽出物、酵素あるいはヒタミン類を
配合するとステイキングを生しやすく、また杵と接触す
る錠剤表面でこれら配合成分の失活、劣化現象が認めら
れたため、本発明においては、これら配合成分を中間層
に配合して、ステイキング及び配合成分の失活、劣化を
防止する。In addition, staking tends to occur when oils, crude drug extracts, enzymes, or hitamines are blended, and deactivation and deterioration phenomena of these blended ingredients have been observed on the tablet surface that comes into contact with the punch. The ingredients are blended into the intermediate layer to prevent staking, deactivation, and deterioration of the ingredients.
本発明において使用するこれらの配合成分について以下
例示する。Examples of these ingredients used in the present invention are given below.
〈オイル〉
イソプロピルパルミテート、イソプロピルごリステート
、スクヮラン、オリーブ油、ホホバ油。<Oil> Isopropyl palmitate, isopropyl restate, squalane, olive oil, jojoba oil.
大豆柚、流動パラフィン、ワセリン、テレピン油うノリ
ン油、トリ （カプリル−カプリン酸）グリセリン、マ
カデごアンナンッ油、ロースヒッフ油等
〈生薬抽出物〉
以下の各生薬の水、アルコール又は多価アルコール若し
くはこれらの混合物を抽出溶媒として抽出した抽出物及
び上記オイルで抽出したもの。Soybean citron, liquid paraffin, vaseline, turpentine oil, tri (caprylic-capric acid) glycerin, macaque oil, loin oil, etc. (Herbal medicine extracts) Water, alcohol or polyhydric alcohol of each of the following herbal medicines, or these An extract obtained by using a mixture of as an extraction solvent and an extract obtained by extracting with the above oil.
（生薬）ソウジュッ、ビヤクジュツ カノコソウケイガ
イ、コウボク、センキエウ、トウヒ、 ｌ−ウキ、シ
ョウキョウ末、ニンジン、ケイヒ シャクヤク、ハツカ
葉、オウゴン、サンシン ブクリヨウ、ドクカッ、ショ
ウブ、ガイヨウ、マツブザ、ビヤクシ、ジュウヤク、リ
ュウノウ。(Herbal medicines) Sojutsu, Biyakujutsu Sojutsu, Biyakujutsu Canokosou kaigai, Kouboku, Senkieus, spruce, l-uki, ginger powder, carrot, cinnamon tree, peony, honeysuckle leaf, scutellariae, sansin bukuriyo, dokukka, calamus, staghorn, pine buza, biyakushi, jyuyaku, rhyuno .
ザフラン、オウバクエキス、チンピ、ウィキョウ、カン
ピ末、カミツレ、メリッサ、ローズマリー、マロニエ、
西洋ノコギリ草、アルニヵ等〈ビタミン〉
ビタ、ＨンＡ、Ｂ、Ｃ，Ｄ、Ｅ及びその誘導体〈酵 素
〉
プロテアーゼ、リパーゼ、アミラーゼ等さらに本発明に
おいては、上下層と中間層とに各々異なった色素および
／または香料成分を配合する。これにより、浴湯溶解時
においてまず上下層が溶解して上下層中に配合した色素
および／または香料成分が溶は出し、次いで上下層の溶
解後、中間層が溶解し始め上下層中の色素あるいは香料
とは異なる中間層中の色素および／または香料成分が溶
は出す。入浴者は経時的に異なった香りや色を楽しむこ
とができる。Zaffron, Auronicum extract, Chinpi, Fennel, Campi powder, Chamomile, Melissa, Rosemary, Horse chestnut,
Western yarrow, arnica, etc. <Vitamins> Vita, H. A, B, C, D, E and their derivatives <Enzymes> Protease, lipase, amylase, etc. Furthermore, in the present invention, the upper and lower layers and the middle layer each have different Add pigment and/or fragrance ingredients. As a result, when dissolving in the bath water, the upper and lower layers first dissolve, and the pigment and/or fragrance ingredient contained in the upper and lower layers are dissolved, and then, after the upper and lower layers are dissolved, the middle layer begins to dissolve. Alternatively, the pigment and/or perfume component in the intermediate layer, which is different from the perfume, dissolves. Bathers can enjoy different scents and colors over time.
本発明において使用する色素類、香料成分を以下に例示
する。The pigments and fragrance components used in the present invention are illustrated below.
〈色素類〉
赤色３号、黄色４号、緑色３号、青色１号、赤１０４号
の１．赤１０６号、赤色２１３号、橙色２０５号、黄色
２０２号の１．緑色２０４号、青色２号等の厚生省令タ
ール色素別表１及びＨの色素、クロロフィルリボフラビ
ン、アンナツト、カンタキサンチンクロシン、コチニー
ル、べにばな、アントラキノン等の食品添加剤として認
められる天然色素〈香料成分〉
レモン系香料、ジャスミン系香料、フローラル０
系香料、シブレ系香料、オリエンタル系香料、ローズ系
香料、ラベンダー系香料、フローラルブーケ系香料、フ
ローラルグリーン系香料、フローラルアルデヒド系香料
、フルーティフローラル系香料、ムスク系香料、バルサ
ム系香料、アニマルグリーン系香料、シトラスグリーン
系香料、レザー系香料、ハーバル系香料、スパイシー系
香料、フゼア系香料
その他、本発明の三層錠又は三層錠においては通常浴剤
で配合できる成分はいずれも使用できる。<Pigments> Red No. 3, Yellow No. 4, Green No. 3, Blue No. 1, Red No. 104. 1. Red No. 106, Red No. 213, Orange No. 205, Yellow No. 202. Natural pigments recognized as food additives (flavoring ingredients) such as green No. 204, blue No. 2, tar pigments listed in Attached Table 1 and H of the Ministry of Health and Welfare ordinance, chlorophyll riboflavin, annatto, canthaxanthin crocin, cochineal, safflower, anthraquinone, etc. 〉 Lemon fragrance, jasmine fragrance, floral 0 fragrance, cible fragrance, oriental fragrance, rose fragrance, lavender fragrance, floral bouquet fragrance, floral green fragrance, floral aldehyde fragrance, fruity floral fragrance, Musk fragrances, balsam fragrances, animal green fragrances, citrus green fragrances, leather fragrances, herbal fragrances, spicy fragrances, fougere fragrances, and other usual bath additives in the three-layer tablet or three-layer tablet of the present invention. Any ingredient that can be blended can be used.
これらには例えば以下の成分を挙げることができる。These include, for example, the following components.
〈その他浴剤添加物〉
無 機 塩：塩化ナトリウム、硫酸ナトリウム硫酸マグ
ネシウム、硝酸カリウム
硝酸ナトリウム、ポリリン酸ナト
リウム、チオ硫酸ナトリウム、ホ
ウ酸、無水ケイ酸、ミュウハン。<Other bath additives> Inorganic salts: sodium chloride, sodium sulfate, magnesium sulfate, potassium nitrate, sodium nitrate, sodium polyphosphate, sodium thiosulfate, boric acid, silicic anhydride, Muhan.
硫酸アルくニウム等
アルコール類 ：エタノール、ステアリルアルコール
イソプロピルアルコール セ
チルアルコール、ヘキサデシルア
ルコール、オクチルドデカノール
グリセリン、１，３−ブチレングリ
コール、プロピレングリコール
ソルビトール、マルチノール等
界面活性剤：アルキル硫酸ナトリウム、ポリオキシエチ
レンアルキルエーテル
硫酸塩、ラウリン酸ジェタノール
アミド、両性界面活性剤等
〔実施例〕
以下、実施例により本発明の詳細な説明する。Alcohols such as alkyl sulfate: ethanol, stearyl alcohol, isopropyl alcohol, cetyl alcohol, hexadecyl alcohol, octyldodecanol glycerin, 1,3-butylene glycol, propylene glycol sorbitol, martinol, etc. Surfactants: sodium alkyl sulfate, polyoxy Ethylene alkyl ether sulfate, lauric acid jetanolamide, amphoteric surfactant, etc. [Examples] Hereinafter, the present invention will be explained in detail with reference to Examples.
実施例１〜５
以下の第工表の各層の成分配合比にしたがって成分を調
合し、第２表に示した各層の重量比にしたがい、直径φ
２０ｍｍ、総重量５ｇの三層錠を作成した。Examples 1 to 5 Components were mixed according to the composition ratio of each layer in Table 2 below, and the diameter φ was adjusted according to the weight ratio of each layer shown in Table 2.
Three-layer tablets with a diameter of 20 mm and a total weight of 5 g were prepared.
：層錠の作成は、菊水製作所製三層錠機ＲＴ−３１，３
６を使用して打錠することにより行った。: The layered tablets were made using a three-layer tablet machine manufactured by Kikusui Seisakusho RT-31,3.
This was done by tabletting using 6.
１
２
第２表 各層重量比
第３表
次に比較例として、第１表及び第２表から算出される各
実施例の配合成分量のトータルと配合成分量が同一にな
る様に以下の第３表の処方を組み、打錠機Ｎｏ、８ Ｆ
−３Ｂを使用してφ２０ｍｍ重量５ｇの単層錠を打錠
した。なお、各比較例の番号と各実施例の番号とは対応
し、１・−タルの配合成分量は同一のものである。1 2 Table 2 Weight ratio of each layer Table 3 Next, as a comparative example, the following table was prepared so that the total amount of ingredients in each example calculated from Tables 1 and 2 was the same as the amount of ingredients in each example. Combine the prescriptions in Table 3 and press tablet machine No. 8F.
Single-layer tablets with a diameter of 20 mm and a weight of 5 g were compressed using -3B. Note that the number of each comparative example corresponds to the number of each example, and the amounts of 1-tal ingredients are the same.
（木頁以下余白）
４
５
木三層錠と比較例の単層錠を各々３０００錠打錠し、打
錠障害を調べた。(Left space below the wooden page) 4 5 3000 tablets of each of the three-layer wooden tablet and the single-layer tablet of the comparative example were compressed, and tableting failure was examined.
結果を以下、第４表に示す。The results are shown in Table 4 below.
第４表 打錠障害の評価
次に溶解時の色や香りの変化の評価を以下の様に行った
。Table 4: Evaluation of tableting failure Next, changes in color and aroma upon dissolution were evaluated as follows.
第１表、第２表（実施例３〜５）に示した各層の成分配
合比及び各層の重量比にしたがい直径φ４０〜５０ｍｍ
、重量３０〜５０ｇの三層錠を作成した。Diameter φ40 to 50 mm according to the composition ratio of each layer and the weight ratio of each layer shown in Table 1 and Table 2 (Examples 3 to 5)
, three-layer tablets weighing 30 to 50 g were prepared.
この三層錠の打錠は、上下杆臼を独自に作り臼に下杵を
セットシあらかしめ混合された下層、中間層、上層の所
定量を静かに流し込み上杵をセットし上下方向にＩＲ用
プレス機を用いプレスすることにより行った。To make this three-layer tablet, we made our own upper and lower mortar, set the lower punch in the mortar, gently poured the predetermined amount of the mixed lower layer, middle layer, and upper layer, set the upper punch, and moved the IR in the vertical direction. This was done by pressing using a press machine.
得られた三層錠を４２’Ｃ、２００ｆｆの浴湯に投入し
色や香りの変化を調べた結果を第５表に示す。The obtained three-layer tablets were placed in bath water at 42'C and 200ff, and changes in color and aroma were examined. The results are shown in Table 5.
（木頁以下余白）
○ ステイキングなし
△ ステイキング有り
× ステイキングひどく、途中で打錠できなくなる
６
７
第５表
色
香りの変化
実施例６
以下、第６表に三層錠における各層の成分配合比及びそ
のスティッキング効果を比較例と共に示す。(Left space below the wooden page) ○ No staking △ With staking × Staking is so severe that it becomes impossible to press the tablet halfway 6 7 5. Color and aroma change Example 6 Below, Table 6 shows the ingredients of each layer in the three-layer tablet. The blending ratio and its sticking effect are shown together with comparative examples.
（木頁以下余白）
〔発明の効果〕
以上の実施例に示した通り、本発明の三層錠又は三層錠
においては打錠障害（ステイキング）の発生が極めて効
果的に防止されている。そしてこのことにより打錠障害
を防止するための滑沢剤の使用量を減らずことが可能と
なり、浴場を汚すことがない。しかも、本発明の三層錠
においてはオイル、生薬抽出物、ビタくン、酵素等も打
錠障害を生ずる恐れなく配合できまた、これらの成分の
劣化、変質も抑制し得るものである。(Left space below the wooden page) [Effects of the Invention] As shown in the above examples, the occurrence of tableting failure (staking) is extremely effectively prevented in the three-layer tablet or three-layer tablet of the present invention. . This makes it possible to avoid reducing the amount of lubricant used to prevent tableting failure, and the bathroom will not be soiled. Moreover, in the three-layer tablet of the present invention, oils, crude drug extracts, vitamins, enzymes, and the like can be incorporated without the risk of tableting problems, and deterioration and deterioration of these components can also be suppressed.
さらに、三層錠の上下層及び中間層の各々の異なる色素
あるいは香料成分を配合でき入浴時において色や香りの
変化も楽しむことができるものであって本発明により画
期的な入浴剤を提供することができた。Furthermore, the present invention provides an innovative bath additive that allows the combination of different pigments or fragrance ingredients for each of the upper and lower layers and the middle layer of the three-layer tablet, allowing users to enjoy changes in color and scent during bathing. We were able to.
Claims (1)
剤において、上下層における酸及び炭酸塩のいずれか一
方の配合量が、他方に対して化学当量に換算して少なく
なるように配合するとともに中間層において酸または炭
酸塩のいずれか一方の不足分を配合することを特徴とす
る発泡入浴剤。 ２、上下層における酸と炭酸塩が当量比として０．０５
〜０．５：１または１：０．０５〜０．５になるように
配合するとともに上中下層全体の酸と炭酸塩の当量比が
０．７〜１．３：１になるように酸あるいは炭酸塩の不
足分を中間層に配合せしめた請求項１記載の発泡入浴剤
。 ３、上下層に滑沢剤を配合した請求項１又は２記載の発
泡入浴剤。 ４、各層に異なる色素及び／又は香料成分を配合した請
求項１〜３いずれか記載の発泡入浴剤。 ５、中間層にオイル、生薬抽出物、酵素、ビタミンから
選ばれた１種以上を配合した請求項１〜４いずれか記載
の発泡入浴剤。 ６、酸及び炭酸塩を含有する二層構造を有する発泡入浴
剤において、上下層における酸及び炭酸塩のいずれか一
方の配合量が、他方に対して化学当量に換算して少なく
なるように配合することを特徴とする発泡入浴剤。[Claims] 1. In a foaming bath additive having a three-layer structure containing an acid and a carbonate, the blending amount of either the acid or the carbonate in the upper or lower layer is equivalent to the chemical equivalent of the other layer. 1. A foaming bath agent characterized in that the amount of acid or carbonate is added in the middle layer to compensate for the deficiency of either acid or carbonate. 2. The equivalence ratio of acid and carbonate in the upper and lower layers is 0.05
Blend the acid so that the ratio is ~0.5:1 or 1:0.05~0.5, and the equivalent ratio of acid and carbonate in the entire upper, middle, and lower layers is 0.7~1.3:1. The foaming bath additive according to claim 1, wherein the carbonate content is added to the intermediate layer. 3. The foaming bath additive according to claim 1 or 2, wherein the upper and lower layers contain a lubricant. 4. The foaming bath additive according to any one of claims 1 to 3, wherein each layer contains a different pigment and/or fragrance component. 5. The foaming bath additive according to any one of claims 1 to 4, wherein the middle layer contains one or more selected from oils, crude drug extracts, enzymes, and vitamins. 6. In a foaming bath additive having a two-layer structure containing an acid and a carbonate, the amount of either the acid or the carbonate in the upper or lower layer is smaller than the other in terms of chemical equivalent. A foaming bath additive that is characterized by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20698689A JP2841517B2 (en) | 1989-08-11 | 1989-08-11 | Bath additive |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20698689A JP2841517B2 (en) | 1989-08-11 | 1989-08-11 | Bath additive |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0374321A true JPH0374321A (en) | 1991-03-28 |
| JP2841517B2 JP2841517B2 (en) | 1998-12-24 |
Family
ID=16532287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20698689A Expired - Lifetime JP2841517B2 (en) | 1989-08-11 | 1989-08-11 | Bath additive |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2841517B2 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001028513A3 (en) * | 1999-10-16 | 2001-11-01 | Henkel Kgaa | Bath tablets |
| WO2011154727A3 (en) * | 2010-06-07 | 2012-06-07 | Cosmetic Warriors Ltd | Effervescent bath composition |
| WO2016170335A1 (en) * | 2015-04-22 | 2016-10-27 | Cosmetic Warriors Limited | Lathering bathing composition |
| JP2017031072A (en) * | 2015-07-30 | 2017-02-09 | 花王株式会社 | Solid effervescent bath preparation |
| WO2017037464A1 (en) * | 2015-09-04 | 2017-03-09 | Cosmetic Warriors Limited | Coloured surfactant composition |
| PL424883A1 (en) * | 2018-03-14 | 2019-09-23 | Bąbelek Zbigniew Octagon International Trade | Urea-containing cosmetic composition for bath and method for producing it |
| WO2020114679A1 (en) | 2018-12-06 | 2020-06-11 | Beiersdorf Ag | A solid cosmetic cleansing composition |
-
1989
- 1989-08-11 JP JP20698689A patent/JP2841517B2/en not_active Expired - Lifetime
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001028513A3 (en) * | 1999-10-16 | 2001-11-01 | Henkel Kgaa | Bath tablets |
| WO2011154727A3 (en) * | 2010-06-07 | 2012-06-07 | Cosmetic Warriors Ltd | Effervescent bath composition |
| JP2013528203A (en) * | 2010-06-07 | 2013-07-08 | コスメティック ウォリアーズ エルティーディー | Composition |
| US8697621B2 (en) | 2010-06-07 | 2014-04-15 | Cosmetic Warriors Ltd. | Surfactant product comprising two distinct effervescent compositions |
| AU2011263481B2 (en) * | 2010-06-07 | 2016-07-28 | Cosmetic Warriors Ltd | Effervescent bath composition |
| WO2016170335A1 (en) * | 2015-04-22 | 2016-10-27 | Cosmetic Warriors Limited | Lathering bathing composition |
| US10596101B2 (en) | 2015-04-22 | 2020-03-24 | Cosmetic Warriors Limited | Lathering bathing composition |
| JP2017031072A (en) * | 2015-07-30 | 2017-02-09 | 花王株式会社 | Solid effervescent bath preparation |
| WO2017037464A1 (en) * | 2015-09-04 | 2017-03-09 | Cosmetic Warriors Limited | Coloured surfactant composition |
| US11052036B2 (en) | 2015-09-04 | 2021-07-06 | Cosmetic Warriors Limited | Coloured surfactant composition |
| PL424883A1 (en) * | 2018-03-14 | 2019-09-23 | Bąbelek Zbigniew Octagon International Trade | Urea-containing cosmetic composition for bath and method for producing it |
| WO2020114679A1 (en) | 2018-12-06 | 2020-06-11 | Beiersdorf Ag | A solid cosmetic cleansing composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2841517B2 (en) | 1998-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080146487A1 (en) | Multiphase bathing tablets | |
| JPH11246390A (en) | Bath preparation having mineral spring effect particularly in the form of foaming tablet and its production and usage | |
| JPH09175992A (en) | Bathing agent tablet filled in capsule | |
| JP5307979B2 (en) | Dispersion | |
| US20130281342A1 (en) | Composition | |
| JPH0374321A (en) | Bathing agent | |
| JP2000229841A (en) | Mixed type bath preparation | |
| JPH09505297A (en) | Sensitively stable denture cleaner tablets | |
| JP2017507111A (en) | Effervescent composition | |
| JP5149614B2 (en) | Bath preparation | |
| RU2667641C2 (en) | Detergent composition | |
| JPH04128218A (en) | Bathing agent | |
| JPH08325137A (en) | Bathing agent | |
| JP7075809B2 (en) | Tablets | |
| JPH05331045A (en) | Bath agent composition | |
| JP2822501B2 (en) | Bath composition | |
| JPS6117509A (en) | Bath salts with hinoki smell | |
| JP7494421B2 (en) | Granule-blended effervescent tablet | |
| JP2811711B2 (en) | Sharp-containing bath composition | |
| JPS6313403B2 (en) | ||
| DE10337814A1 (en) | Multiphase washing, cleaning or body-care tablet comprises a solid compressed powder body with a hole or depression containing an enveloped liquid or pasty phase | |
| JP2008162923A (en) | Method for producing bathing agent | |
| JPH01101399A (en) | Solid detergent | |
| JP2021187784A (en) | Granule-blended foamable tablet | |
| JP2638029B2 (en) | Bath composition |